Compare with Axin (Kishida et al., 1998), a reliable and key target which should now be regarded as a tumor suppressor, the effects of two targets combination APC/β-catenin and β-catenin/TCF with low concentration are extremely similar to Axin. The gene discussed is AXIN1; the disease is neoplasm.